Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China · Delayed Price · Currency is CNY 4.960
+0.020 (0.40%)
Oct 23, 2026, 3:04 PM CST
SHE:300158 Revenue
Shanxi Zhendong Pharmaceutical Co.,Ltd had revenue of 447.38M CNY in the quarter ending June 30, 2026, a decrease of -36.31%. This brings the company's total for the last twelve months to 2.42B, down -17.07% year-over-year. In the year 2025, Shanxi Zhendong Pharmaceutical Co.,Ltd had annual revenue of 2.78B, down -6.33%. That makes Shanxi Zhendong Pharmaceutical Co.,Ltd the 13,182nd largest company in the world by revenue and 2,304th in China.
Revenue (ttm)
2.42B
Revenue Growth
-17.07%
P/S Ratio
2.03
Revenue / Employee
655.65K
Employees
3,695
Market Cap
4.92B
Revenue by Segment
- Pharmaceutical Production and Sales 3.20B 76.7%
- Chinese Herbal Medicine Cultivation 865.38M 20.7%
- Research and Development 104.94M 2.5%
Fiscal year ended Dec 31, 2025 See the full SHE:300158 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.78B | -188.07M | -6.33% |
| Dec 31, 2024 | 2.97B | -654.89M | -18.06% |
| Dec 31, 2023 | 3.63B | -102.54M | -2.75% |
| Jan 1, 2023 | 3.73B | -1.37B | -26.80% |
| Jan 1, 2022 | 5.09B | 245.94M | 5.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.